Information Collection Request

National Syringe Services Program (SSP) Evaluation

ICR 202203-0920-002 · OMB 0920-1359 · Received in OIRA

Forms and Documents
DocumentTypeStatusAvailability
Form 0920-21DC Nonresponse Survey Form and Instruction Unchanged Available
Form 0920-21DC National Syringe Services Program Evaluation Form and Instruction Modified Repair queued
Memo_Non-Substantive Change Request_0920-1359.docx Justification for No Material/Nonsubstantive Change Uploaded 2022-03-01 Repair queued
Attachment 12_Sample Analysis Table.docx Supplementary Document Uploaded 2021-07-16 Repair queued
Attachment 9_Project Determination.docx Supplementary Document Uploaded 2021-07-13 Available
Attachment 5_Model Final Reminder.docx Supplementary Document Uploaded 2021-07-13 Available
Attachment 4_Model Survey Reminders.docx Supplementary Document Uploaded 2021-07-13 Repair queued
Attachment 3_Model Invitation Letter.docx Supplementary Document Uploaded 2021-07-13 Repair queued
Attachment 2_60-Day FRN.pdf Supplementary Document Uploaded 2021-07-13 Missing upstream
Attachment 1_Authorizing Legislation.docx Supplementary Document Uploaded 2021-07-13 Repair queued
Supporting Statement B.docx Supporting Statement B Uploaded 2021-07-13 Repair queued
Supporting Statement_PartA_ 30 day_clean__2021_0701.docx Supporting Statement A Uploaded 2021-07-13 Repair queued
IC Document Collections
IC IDCollectionTypeStatusForm
248418 Nonresponse Survey Form and Instruction Unchanged
248417 National Syringe Services Program Evaluation Form and Instruction Modified
ICR Details
0920-1359 202203-0920-002
Received in OIRA 202107-0920-003
HHS/CDC 0920-22DB
National Syringe Services Program (SSP) Evaluation
No material or nonsubstantive change to a currently approved collection   Yes
Regular 03/01/2022
  Requested Previously Approved
12/31/2024 12/31/2024
960 960
296 296
0 0

The National Syringe Services Program Evaluation (NSSPE) will be used to inform planning and evaluation of prevention programs that aim to reduce injection-related adverse health outcomes among people who inject drugs. The primary goals of the survey are to 1) assess and monitor syringe services programs (SSPs) operations and services, client characteristics and drug use patterns, funding resources, community relations, and key operational and programmatic successes and challenges, and 2) support timely analysis and dissemination of national program evaluation survey findings. CDC will work with an award recipient and North American Syringe Exchange Network (NASEN) to conduct annual surveys.

US Code: 42 USC 241 Name of Law: PHSA
  
None

Not associated with rulemaking

  86 FR 11532 02/25/2021
86 FR 38096 07/19/2021
Yes

2
IC Title Form No. Form Name
National Syringe Services Program Evaluation 0920-21DC, 0920-22DB Survey Year Two/Three ,   Survey Year 1
Nonresponse Survey 0920-21DC Nonresponse Survey

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 960 960 0 0 0 0
Annual Time Burden (Hours) 296 296 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$278,996
Yes Part B of Supporting Statement
    No
    No
No
No
No
No
Odion Clunis 770 488-0045 [email protected]

  Yes
  The changes to the survey which include minor wording changes to the questions, deleting one survey item at the end of the survey, as well as modifying, adding, and separating response options.
Agency/Sub Agency RCF ID RCF Title RCF Status IC Title

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/01/2022